United States: The Impact Of The Inflation Reduction Act Of 2022 On Pharmaceutical Innovation, Patent Litigation And Market Entry - Akin Gump Strauss Hauer & Feld LLP

Mondaq

12 Oct 2022 0 shares 1 views

United States: The Impact Of The Inflation Reduction Act Of 2022 On Pharmaceutical Innovation, Patent Litigation And Market Entry - Akin Gump Strauss Hauer & Feld LLP

Mondaq

Published 12 Oct 2022

The Inflation Reduction Act of 2022 (IRA) was signed into law by President Biden on August 16, 2022, and includes key sections addressing climate and clean energy, corporate taxes and health care.

Full Article

United States: HHS Is Moving ‘Full Steam Ahead' With The Implementation Of The Inflation Reduction Act: Here Are The Key Health Care Reform Effective Dates - Akin Gump Strauss Hauer & Feld LLP

The Inflation Reduction Act (IRA), P.L. 117-169, which became law on August 16th, included some of the most consequential..

Mondaq 10 Oct 2022

United States: IRS Issues Request For Public Comment On Clean Energy And Climate Provisions Included In Inflation Reduction Act - Akin Gump Strauss Hauer & Feld LLP

On October 5, 2022, the Department of Treasury and Internal Revenue Service (IRS) released six Notices requesting comments on..

Mondaq 07 Oct 2022

United States: The Impact Of The Inflation Reduction Act Of 2022 On Pharmaceutical Innovation, Patent Litigation And Market Entry - Akin Gump Strauss Hauer & Feld LLP

United States: The Impact Of The Inflation Reduction Act Of 2022 On Pharmaceutical Innovation, Patent Litigation And Market Entry - Akin Gump Strauss Hauer & Feld LLP

You might like

Related news coverage

United States: HHS Is Moving ‘Full Steam Ahead' With The Implementation Of The Inflation Reduction Act: Here Are The Key Health Care Reform Effective Dates - Akin Gump Strauss Hauer & Feld LLP

United States: IRS Issues Request For Public Comment On Clean Energy And Climate Provisions Included In Inflation Reduction Act - Akin Gump Strauss Hauer & Feld LLP

Advertisement